Is Xeris Biopharma Holdings, Inc. (XERS) a Buy, Sell, or Hold?
Xeris Biopharma Holdings, Inc.
NASDAQ:XERS
$8.7 USD
$0.42 (5.07%)
- Volume
- 1.42M
- Average Volume
- 1.88M
- Market Capitalization
- $1.5B
- P/E Ratio
- 122.88
- Dividend Yield
- 0.00%
- Price Target
- $6.60
- Year High
- $10.08
- Year Low
- $4.87
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.12
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.38%
Investors Holding
6
change: -238 | last: 244
Increased Positions
3
change: -142 | last: 145
Reduced Positions
2
change: -53 | last: 55
New Positions
0
change: -47 | last: 47
Sold Positions
229
change: 190 | last: 39
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -69.4614 | last: 0.6946
Total Invested
5.31M
XERS Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $7.85 | 160.43M | $1.26B | $111.04M | $37.76M | $1.19B |
| 2024-12-31 | $3.39 | 146.77M | $497.56M | $71.62M | $271.45M | $697.39M |
| 2023-12-31 | $2.35 | 137.67M | $323.54M | $67.45M | $229.19M | $485.28M |
| 2022-12-31 | $1.33 | 135.63M | $180.39M | $121.97M | $198.06M | $256.48M |
| 2021-12-31 | $2.93 | 79.03M | $231.55M | $67.27M | $88.07M | $252.35M |
| 2020-12-31 | $4.92 | 42.64M | $209.8M | $37.6M | $87.02M | $259.23M |
| 2019-12-31 | $7.05 | 26.11M | $184.08M | $19.52M | $58.3M | $222.86M |
| 2018-12-31 | $17.00 | 12.05M | $204.78M | $45.72M | $31.89M | $190.96M |
| 2017-12-31 | $20.22 | 2.03M | $41.01M | $42.04M | $- | $-1.03M |
| 2016-12-31 | $20.22 | 1.84M | $37.25M | $32.27M | $- | $4.98M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5.80 | 170.52M | $989.03M | $111.75M | $37.33M | $914.61M |
| 2025-12-31 | $7.85 | 165.96M | $1.3B | $111.04M | $37.76M | $1.23B |
| 2025-09-30 | $8.14 | 177.62M | $1.45B | $91.6M | $38.18M | $1.39B |
| 2025-06-30 | $4.67 | 155.97M | $728.39M | $59.28M | $257.22M | $926.33M |
| 2025-03-31 | $5.49 | 152.45M | $836.93M | $58.44M | $268.75M | $1.05B |
| 2024-12-31 | $3.39 | 149.09M | $505.42M | $71.62M | $271.45M | $705.25M |
| 2024-09-30 | $2.85 | 148.99M | $424.63M | $59.23M | $270.96M | $636.37M |
| 2024-06-30 | $2.17 | 148.35M | $321.91M | $57.6M | $269.8M | $534.11M |
| 2024-03-31 | $2.14 | 140.51M | $300.7M | $62.69M | $268.7M | $506.7M |
| 2023-12-31 | $2.35 | 138.12M | $324.59M | $67.45M | $229.19M | $486.34M |
| 2023-09-30 | $1.86 | 138.06M | $256.79M | $46.14M | $227.94M | $438.59M |
| 2023-06-30 | $2.62 | 137.34M | $359.83M | $46.17M | $224.99M | $538.64M |